It has been reported that CLUL1, CNGB1, ROM1, LRRC39, and RDH12 genes in different retinoblastoma subtypes are involved in the progression and development of the disease, which can be useful as biomarkers (M. [54]). This evidence concerns the gene CLUL1 and retinoblastoma.